Invicta Diagnostic Current Share Price | Invicta Diagnostic Stock Screener
INVICTA
Healthcare Service Provider
Invicta Diagnostic Current Stock Price Today
Track the current Invicta Diagnostic share price and stock price live with TickJournal's free stock screener.
Browse Invicta Diagnostic annual reports to support your investment research.
Use the Invicta Diagnostic stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Invicta Diagnostic Market Cap
₹81.84 Cr.
INVICTA P/E Ratio (TTM)
-
Invicta Diagnostic P/B Ratio
1.69
EPS (TTM)
₹4.90
Dividend Yield
-
Debt to Equity
0.11
INVICTA 52 Week High
-
Invicta Diagnostic 52 Week Low
-
Operating Margin
-
Profit Margin
-
INVICTA Revenue (TTM)
-
EBITDA
-
Net Income
-
Total Assets
₹60.00
Total Equity
₹50.00
Invicta Diagnostic Current Share Price Chart
Track the current Invicta Diagnostic share price and stock price with an interactive chart. Analyse INVICTA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Invicta Diagnostic stock quote in one place.
Invicta Diagnostic Company Profile - Fundamental Screener
Screen Invicta Diagnostic company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for INVICTA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0XJ501010
Invicta Diagnostic Balance Sheet Screener
Screen INVICTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
| Assets | |||
| Total Assets | 60 | 21 | 16 |
| Current Assets | 34 | 6 | 4 |
| Fixed Assets | 19 | 10 | 12 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 3 | 5 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 50 | 14 | 11 |
| Share Capital | 13 | 8 | 0 |
| Reserves & Surplus | 37 | 5 | 12 |
Invicta Diagnostic Income Statement Screener - Profit & Revenue Analysis
Screen Invicta Diagnostic income statement and profit fundamentals.
Analyze INVICTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Invicta Diagnostic share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March |
|---|---|---|---|---|
| Revenue | 0 | 33 | 30 | 8 |
| Expenses | 0 | 23 | 21 | 5 |
| EBITDA | 0 | 11 | 9 | 4 |
| Operating Profit % | 0.00% | 30.00% | 31.00% | 43.00% |
| Depreciation | 0 | 3 | 3 | 1 |
| Interest | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 7 | 7 | 3 |
| Tax | 0 | 2 | 2 | 0 |
| Net Profit | 0 | 5 | 5 | 3 |
| EPS | 0.00 | 4.90 | 5.86 | 3.19 |
Invicta Diagnostic Cash Flow Screener - Liquidity Fundamentals
Screen INVICTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March |
|---|---|---|---|
| Operating Activities | 3 | 7 | 4 |
| Investing Activities | -14 | -5 | -10 |
| Financing Activities | 31 | -1 | 7 |
| Net Cash Flow | 20 | 1 | 1 |
Invicta Diagnostic Shareholding Pattern Screener
See Invicta Diagnostic shareholding pattern with promoter, FII, and DII holdings.
Check Invicta Diagnostic promoter holding and ownership changes for INVICTA on TickJournal.
| Item | 2026-Mar | 2025-Nov | 2025-Dec | 2024-Aug |
|---|---|---|---|---|
| Promoter Holding | 66.70% | 90.52% | 66.70% | 100.00% |
| FII Holding | 4.20% | 0.00% | 0.94% | 0.00% |
| DII Holding | 4.30% | 0.00% | 10.22% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.71% | 0.00% | 18.49% | 0.00% |
| Other Holding | 6.10% | 9.48% | 3.66% | 0.00% |
| Shareholder Count | 411 | 34 | 34 | 14 |
Invicta Diagnostic Share Dividend Screener - Share Yield Analysis
Check Invicta Diagnostic dividend history with payout and yield data.
View Invicta Diagnostic dividend details including ex-dates and amounts for INVICTA stock.
Invicta Diagnostic Stock Index Membership
See which indices include Invicta Diagnostic stock.
Check INVICTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Invicta Diagnostic Market Events Screener - Corporate Actions
Get Invicta Diagnostic corporate actions including splits, bonuses, and buybacks.
Check Invicta Diagnostic stock events that may affect INVICTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-25 | 2026-08-25 | Quarterly Result Announcement | NA | 0.00% |
| 2026-05-18 | 2026-05-18 | Quarterly Result Announcement | NA | 3.95% |
| 2026-04-17 | 2026-04-17 | Extraordinary General Meeting | NA | 2.74% |
Invicta Diagnostic Competitors Screener - Peer Comparison
Screen INVICTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 31,779 | 58.53 | 2,864 | 12.11% | 510 | 50.15 |
| Vijaya Diagnostic Centre | 14,800 | 79.29 | 835 | 19.34% | 173 | 43.94 |
| Metropolis Healthcare | 12,043 | 58.52 | 1,671 | 24.15% | 191 | 51.85 |
| Thyrocare Technologies | 8,616 | 49.29 | 846 | 20.48% | 163 | 36.40 |
| Nephrocare Health Services | 7,377 | 86.55 | 1,023 | 32.93% | 77 | 57.81 |
| Krsnaa Diagnostics | 1,740 | 18.02 | 773 | 4.05% | 106 | 41.90 |
| Suraksha Diagnostic | 1,702 | 47.71 | 314 | 22.55% | 31 | 57.03 |
| 3B BlackBio DX | 1,109 | 20.67 | 142 | 27.17% | 61 | 43.43 |
| One Global Service Provider | 1,026 | 13.73 | 499 | 237.48% | 70 | 42.00 |
| Health X Platform | 948 | -36.56 | 1,319 | 12.68% | -3 | 47.04 |
Invicta Diagnostic Company Announcements - News Screener
Screen INVICTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.